Research analysts who have asked questions during MATERIALISE earnings calls.
Recent press releases and 8-K filings for MTLS.
Materialise NV Reports H1 2025 Results and Provides Full-Year 2025 Guidance
MTLS
Earnings
Guidance Update
Share Buyback
- Materialise NV reported H1 2025 revenue of €131,210 thousand, a (0.9)% year-over-year decrease, and a net loss of €337 thousand, resulting in basic EPS of (€0.01).
- The company provided full-year 2025 guidance, targeting consolidated revenue between €265 million and €280 million and Adjusted EBIT between €6 million and €10 million.
- The Manufacturing segment revenue declined by 16% in H1 2025 compared to the prior year, as the company transitions from prototyping to certified manufacturing of end-use parts in aerospace, medtech, and semiconductors.
- Materialise NV has never paid cash dividends and has no present intention to do so, but has an announced ADS buyback program.
- The company's international operations, which generated only 2.5% of revenue in Belgium in 2024, expose it to global economic, social, political, and operational risks, including geopolitical instability.
Nov 18, 2025, 9:50 PM
Materialise Reports Q3 2025 Financial Results
MTLS
Earnings
Guidance Update
Demand Weakening
- Materialise reported consolidated revenue of €66.3 million for Q3 2025, representing a 3.5% decrease compared to Q3 2024, though it grew 2% compared to Q2 2025.
- The Medical segment achieved an all-time revenue record of €33.3 million, growing over 10% year-over-year, while the Software and Manufacturing segments experienced declines of 7% and 17%, respectively, primarily due to macroeconomic headwinds.
- The company's gross profit margin remained strong at 56.8% in Q3 2025, and adjusted EBIT amounted to €2.9 million (4.4% of revenue), leading to a net profit of €1.8 million.
- Materialise's net cash position increased to €67.7 million, driven by strong free cash flow during the quarter.
- The company maintained its full-year 2025 guidance, expecting revenues in the range of €265 to €280 million and adjusted EBIT between €6 and €10 million.
Oct 28, 2025, 12:30 PM
Materialise Announces Q3 2025 Financial Results
MTLS
Earnings
Guidance Update
Demand Weakening
- Materialise reported Q3 2025 revenue of 66.3 mEUR, a 3.5% decrease from Q3 2024, with net profit at 1.8 mEUR or 0.03 EUR per share.
- Adjusted EBIT for Q3 2025 was 2.9 mEUR, representing 4.4% of revenue and a 34% decrease compared to Q3 2024, while Adjusted EBITDA decreased 15% to 8.4 mEUR.
- The Medical segment saw revenue increase 10.3% to 33.3 mEUR, but the Software and Manufacturing segments experienced revenue decreases of 7% and 17% respectively, partly due to macro-economic headwinds.
- The company's net cash position increased by 6.7 mEUR from year-end 2024 to 67.7 mEUR at the end of Q3 2025.
- Materialise is maintaining its 2025 financial guidance, expecting consolidated revenue between 265 - 280 mEUR and consolidated Adjusted EBIT between 6 - 10 mEUR.
Oct 28, 2025, 12:30 PM
Materialise Reports Q3 2025 Financial Results
MTLS
Earnings
Guidance Update
Demand Weakening
- Materialise's consolidated revenue for Q3 2025 was EUR 66.3 million, representing a 3.5% decrease compared to Q3 2024, though it grew by 2% from Q2 2025.
- The Materialise Medical segment achieved a record revenue of EUR 33.3 million, growing by over 10% year-over-year, while the Software and Manufacturing segments experienced declines of 7% and 17%, respectively, impacted by macroeconomic headwinds.
- Adjusted EBIT for the third quarter of 2025 amounted to EUR 2.9 million, resulting in a 4.4% margin, and the company generated a net profit of EUR 1.8 million.
- The company's net cash position further increased to EUR 67.7 million at the end of Q3 2025.
- Materialise maintained its full-year 2025 guidance, expecting revenues in the range of EUR 265 million to EUR 280 million and adjusted EBIT between EUR 6 million and EUR 10 million.
Oct 28, 2025, 12:30 PM
Materialise NV Reports Third Quarter 2025 Results
MTLS
Earnings
Guidance Update
Demand Weakening
- Materialise NV's total consolidated revenue for the third quarter of 2025 decreased 3.5% to 66,259 kEUR compared to the third quarter of 2024.
- Net profit for Q3 2025 was 1,848 kEUR, or 0.03 EUR per diluted share.
- Revenue from the Materialise Medical segment grew 10.3% to 33,296 kEUR in Q3 2025, while the Materialise Manufacturing segment's revenue decreased 17.1% to 22,677 kEUR.
- The company's net cash position increased by 6,724 kEUR to 67,744 kEUR as of September 30, 2025, compared to December 31, 2024.
- Materialise maintained its full-year 2025 guidance, expecting revenues between 265,000 kEUR and 280,000 kEUR and Adjusted EBIT between 6,000 kEUR and 10,000 kEUR.
Oct 28, 2025, 12:12 PM
Quarterly earnings call transcripts for MATERIALISE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more